期刊文献+

cAMP—PKA信号转导通路在缺血预处理减轻大鼠离体心脏缺血再灌注损伤中的作用

Role of cAMP-PKA signal transduction pathway in the ischemic preconditioning-induced attenuation of ischemia-reperfusion injury in isolated rat hearts
原文传递
导出
摘要 目的探讨cAMP-PKA信号转导通路在缺血预处理减轻大鼠离体心脏缺血再灌注损伤中的作用。方法成年SD大鼠50只,体重300~350g,采用Langendorff装置建立大鼠离体心脏缺血再灌注模型后随机分为5组(n=10):缺血再灌注组(IR组)、缺血预处理组(IPC组)、H89组、脯氨酸二硫氨基甲酸组(PDTC组)和双丁酰环磷酸腺苷组(db-cAMP组)。K-H液平衡灌注10min后,R组K-H液继续灌注30min后停灌1h,再灌注30min;IPC组停灌5min,再灌注5rain,反复3次,停灌1h再灌注30min;PDTC和H89组停灌5min,分别用含有PDTC100μmol/L和含有H8910μmol/L的K-H液再灌注5min,反复3次,余同IPC组;db-cAMP组用含db—cAMP200μmol/L的K.H液灌注30min,停灌1h再灌注30rain。于平衡灌注10min、再灌注10、20和30min时记录左心室压力最大变化速率(±dp/dt max)和左心室发展压(LVDP)。于平衡灌注10rain和再灌注30rain时记录冠脉流出量(CF);测定冠脉流出液中乳酸脱氢酶(LDH)和磷酸肌酸激酶(CK)活性。于再灌注30min时取心肌组织,采用EMSA法检测NF-κB-DNA结合活性,采用RT—PCR法检测TNF-α mRNA表达,采用Western blot法检测磷酸化环腺苷酸反应元件结合蛋白(p-CREB)(Ser133)表达。结果与IR组比较,IPC组和db-cAMP组NF-κB-DNA结合活性和TNF-α mRNA表达降低,±dp/dtmax 和CF升高,CK和LDH活性降低,IPC组、PDTC组和db-cAMP组P—CREB(Serl33)表达升高(P〈0.05或0.01);与IPC组比较,H89组和PDTC组NF-κB-DNA结合活性和TNF—dmRNA表达升高,±dp/dt max、LVDP和CF降低,CK和LDH活性升高,H89组p-CREB(Ser133)表达降低(P〈0.05或0.01)。结论缺血预处理通过激活cAMP-PKA信号转导通路抑制NF-κB-DNA结合活性,减少炎性因子的基因转录,从而减轻大鼠离体心脏缺血再灌注损伤。 Objective To investigate the role of cAMP-PKA signal transduction pathway in the ischemic preconditioning-induced attenuation of ischemia-reperfusion (I/R) injury in isolated rat hearts. Methods Fifty healthy adult SD rats weighing 300-350 g were anesthetized with intraperitoneal (IP) pentobarbital 50 mg/kg. Their hearts were excised and perfused in a Langendorff apparatus with 37 ℃ oxygenated (95 % O2-5 % CO2 ) modified K-H solution at a constant pressure of 70 cm H20, and randomly divided into 5 groups (n = 10 each) : group Ⅰ I/R; group Ⅱ ischemic preconditioning (IPC); group Ⅲ H89 (PKA inhibitor); group Ⅳ PDTC (NF-κB inhibitor) and groupV db-cAMP. The experiment started after 10 min stabilization. The isolated hearts were first peffused for 30 min, followed by 60 min ischemia and 30 min reperfusion in group I/R (Ⅰ). Group IPC ( Ⅱ) was subjected to 3 episodes of 5 min ischemia at 5 min intervals before I/R. Group Ⅲ and Ⅳ received 5 min perfusion with H89 10 μmol/L and PDTC 100 μmol/L 3 times at 5 min intervals respectively before I/R. Group V was perfused with db-cAMP 200 μmol/L for 30 min before I/R. Left ventricular developed pressure (LVDP) and + dp/dtm= were measured at stabilization period and 10, 20, 30min of reperfusion. Coronary flow (CF) was measured at stabilization period and 30 min of reperfusion and activities of LDH and creatine kinase (CK) in the coronary effluent were determined. The myocardial specimens were obtained at 30 min of reperfusion for determination of NF-κB-DNA binding activity (by EMSA) and expression of TNF-α mRNA (by RT-PCR ) and p-CREB (Ser133) (by Western blot). Results Compared with I/R group, NF-κB-DNA binding activity and TNF-α mRNA expression were significantly decreased, + dp/dtmax and CF were significantly increased, CK and LHD activities in the coronary effluent were significantly decreased in group IPC and db-cAMP (group Ⅱ , Ⅴ ) and p-CREB (Ser133) expression was significantly increased in group IPC, PDTC and db-cAMP (group Ⅱ, Ⅳ, Ⅴ ). Compared with IPC group, NF-κB-DNA binding activity and TNF-α mRNA expression were significantly increased, ± dp/dtmax, LVDP and CF were significantly decreased, CK and LDH activities were significantly increased in group H89 and PDTC (group m, IV ) and p-CREB (Ser133) expression was significantly decreased in group H89 (group m ). Conclusion Ischemic preconditioning can attenuate I/R injury in isolated hearts by inhibition of NF-κB-DNA binding activity via cAMP-PKA signal transduction pathway which reduces gene transcription of inflammatory eytokine.
出处 《中华麻醉学杂志》 CAS CSCD 北大核心 2009年第3期268-271,共4页 Chinese Journal of Anesthesiology
关键词 环AMP 环AMP依赖性蛋白激酶类 缺血预处理 心肌再灌注损伤 Cyclic AMP Cyclic AMP-dependent protein kinases Ischemic preconditioning Myocardial reperfusion injury
  • 相关文献

参考文献13

  • 1Kevin LG, Katz P, Camara AK, et al. Anesthetic preconditioning: effects on latency to ischemic injury in isolated hearts. Anesthesiology, 2003, 99 : 385-391.
  • 2Kehl F, Krolikowskl JG, Mraovic B, et al. Is isoflurane-induced preconditioning dose related? Anesthesiology, 2002, 96:675-680.
  • 3Sanada S, Kitakaze M, Papst PJ, et at. Cardioprotective effect afforded by transient exposure to phosphodiesterase Ⅲ inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase. Circulation, 2001, 104:705-710.
  • 4Yeh CH, Lin YM, Wu YC, et al. Inhibition of NF-kappaB activation can attenuate ischemia/reperfusion-induced contractility impairment via decreasing cardiomyocytic proinflammatory gene up-regulation and matrix metalloproteinase expression. J Cardiovasc Pharmacol, 2005, 45 : 301- 309.
  • 5Raghunandan R, Ingrain VM. Hyperphosphorylation of the cytoskeletal protein Tau by the MAP-kinase PK40erk2: regulation by prior phosphorylation with cAMP-dependent protein kinase A. Biochem Biophys Res Commun, 1995, 215:1056-1066.
  • 6Gao Y, Gao G, Long C, et al. Enhanced phosphorylation of cyclic AMP response element binding protein in the brain of mice following repetitive hypoxic exposure. Biochem Biophys Res Commun, 2006, 340, 661-667.
  • 7Frances C, Nazeyrollas P, Prevost A,et al. Role of beta 1- and beta 2- adrenoceptor subtypes in preconditioning against myocardial dysfunction after ischemia and reperfasion. J Cardiovasc Pharmacol, 2003,41 : 396- 405.
  • 8Sanada S, Asanuma H, Tsukamoto O, et al. Protein kinase A as another mediator of ischemic preconditioning independent of protein kinase C. Circulation, 2004, 110:51-57.
  • 9Inserte J, Garcia-Dorado D, Ruiz-Meana M, et al. Ischemic preconditioning attenuates calpain-mediated degradation of structural proteins through a protein kinase A-dependent mechanism. Cardiovasc Res, 2004, 64: 105-114.
  • 10Zhong C, Zhou Y, Liu H. Nuclear factor kappaB and anesthetic preconditioning during myocardial ischemia-reperfusion. Anesthesiology, 2004, 100 : 540-546.

二级参考文献8

  • 1李李,沈金美,何小京,常业恬.乌司他丁对体外循环患者血浆细胞因子水平及呼吸指数的影响[J].中华麻醉学杂志,2004,24(8):578-581. 被引量:29
  • 2Murphy GJ, Angelini GD. Side effects of cardiopulmonary bypass: what is the reality? J Card Surg, 2004, 19: 481-488.
  • 3Defraigne JO, Pincemail J, Larbuisson R, et al. Cytokine release and neutrophil activation are not prevented by heparin-coated circuit and approtinin administration. Ann Thorac Surg, 2000, 69: 1084-1091.
  • 4Mcbride WT, Armstrong MA. Cytokine balance and immunosuppressive changes at cardiac surgery: contrasting response between patients and isolated CPB circuit. Br J Anaesth, 1995, 75: 724-733.
  • 5Ollivier V, Parry GC, Cobb RR, et al. Elevated cyclic AMP inhibits NF-κB-mediated transcription in human monocytic cells and endothelial cells. J Biol Chem, 1996, 271: 20828-20835.
  • 6Feng W, Wang Y, Zhang J, et al. Effects of CTx and 8-bromo-cAMP on LPS-induced gene expression of cytokines in murine peritoneal macrophages. Biochem Biophys Res Commun, 2000, 269: 570-573.
  • 7Minguet S, Huber M, Rosenkranz L, et al. Adenosine and cAMP are potent inhibitors of the NF-кB pathway downstream of immunoreceptors.Eur J Immunol, 2005, 35: 31-41.
  • 8张小霓,翁钦永.葡甲胺环腺苷酸用于危重心脏直视手术围术期的临床研究[J].中国新药杂志,2001,10(6):444-447. 被引量:4

共引文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部